NCT03197220

Brief Summary

In this study, 99 overweight or obese women that referred to the Clinic Nutrition to lose weight were randomly divided into three groups according to body mass index (BMI) by random-number table (figure1). We attempted to match all three groups for BMI, probable medications, and age. Subjects were excluded if they had risk factors of cardiovascular diseases or allergic reactions to fish or walnut, or received lowering blood glucose or lipid profile agents. Also, participants with weak economic status could not enter to this study (due to the high cost of fish and walnuts). Before the start of this study, the information in the form of questionnaire about demographic, medical history, and medication use, was completed. Participants were aware about overview of this study, and completed the consent form. The NATIONAL INSTITUTED FOR MEDICAL RESEARCH DEVELOPMENT (NIMAD), approved all procedures involving human subjects. The study has been done in accordance with the ethical standards in declaration of Helsinki. Then all of the three groups received a low-calorie diet in order to lose weight. The distribution of macronutrients was similar in three groups (carbohydrate 55%, fat 33%, and protein 17%). The amount of different fatty acids (saturated, unsaturated with mono double bond, and polyunsaturated fatty acids) intake in these diets was the same but the sources of omega-3 between these groups were different. In the first group, subjects were instructed to consume 300 gram fatty fish, such as Salmon fish during a week in two separated meals (each meal 150 gr fatty fish) and to avoid consumption of plant sources of omega-3 (soybean oil, canola, flaxseed and walnuts). In the second group, subjects were asked to consume walnuts three times a week and each time two walnuts (totally 18 walnuts/wk) and avoid the consumption of fish. And in the third group, subjects were recommended to consume 150 g fatty fish during a week and nine walnuts. The amount of omega-3 fatty acids considered in this study covered the typical recommended intake (0.3 to 0.5 g/d of EPA+DHA and 0.8 to 1.1 g/d of ALA)(14). Dietary intakes of all patients were controlled by a dietitian and they were followed for 12 weeks. Dietary intakes were assessed by three dietary records (one weekend and two week days).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
99

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2015

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 22, 2015

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 21, 2016

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2017

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

March 3, 2017

Completed
4 months until next milestone

First Posted

Study publicly available on registry

June 23, 2017

Completed
Last Updated

April 7, 2020

Status Verified

March 1, 2017

Enrollment Period

1 year

First QC Date

March 3, 2017

Last Update Submit

April 3, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • the change of biochemical factor levels

    Systolic and diastolic blood pressures (SBP and DBP) will measured twice after 15 min of rest in sitting and comfortably position using a standard mercury sphygmomanometer. Blood sugar (FBS) will measured on the day of blood sampling and quantified by colorimetric method by the glucose oxidize technique. hs-CRP will measured by The Immunoturbidimetry method with with a polyclonal antibody (Pars Azmoon Inc). Serum concentrations of, high-density lipoprotein cholesterol(HDL-C), low-density lipoprotein cholesterol (LDL-C) and triglyceride (TG) will quantified using commercially available enzymatic reagents (Pars Azmoon, Tehran, Iran) adapted to an autoanalyzer system (Selectra E, Vitalab, Holliston, the Netherlands).

    12 weeks

Secondary Outcomes (4)

  • height

    12 week

  • weight

    12 week

  • BUN

    12 WEEK

  • creatinine

    12 WEEK

Other Outcomes (4)

  • body mass index

    12 week

  • physical activities

    12 week

  • Hs-CRP

    12 week

  • +1 more other outcomes

Study Arms (3)

fish

EXPERIMENTAL
Other: fish

walnut

EXPERIMENTAL
Other: walnut

fish-walnut

EXPERIMENTAL
Other: fish-walnut

Interventions

fishOTHER

300 gr/week fish

fish
walnutOTHER

18 walnut per week

walnut

150 gr fish and 9 walnut per week

fish-walnut

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Gender Eligibility Detailsoverweight or obese female that referred to the Clinic Nutrition to lose weight
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • over weight or obese

You may not qualify if:

  • have any diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Fatahi S, Haghighatdoost F, Larijani B, Azadbakht L. Effect of Weight Reduction Diets Containing Fish, Walnut or Fish plus Walnut on Cardiovascular Risk Factors in Overweight and Obese Women. Arch Iran Med. 2019 Oct 1;22(10):574-583.

MeSH Terms

Interventions

In Situ Hybridization, FluorescencePR-10 protein, walnut birch pollen

Intervention Hierarchy (Ancestors)

In Situ HybridizationStaining and LabelingHistocytological Preparation TechniquesCytological TechniquesClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisHistological TechniquesInvestigative TechniquesCytogenetic AnalysisGenetic TechniquesNucleic Acid Hybridization

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 3, 2017

First Posted

June 23, 2017

Study Start

November 22, 2015

Primary Completion

November 21, 2016

Study Completion

January 20, 2017

Last Updated

April 7, 2020

Record last verified: 2017-03